Australian researchers believe cannabidiol (CBD) may help alleviate cognitive impairment in patients with schizophrenia, a serious condition that can profoundly affect those suffering from...

A new National Cannabis Study led by a researcher at Johns Hopkins University School of Medicine will track around 10,000 medical cannabis patients across...

A CAD $1.5 million grant has been awarded by the Canadian Institutes of Health Research’s Institute of Cancer Research and the Canadian Cancer Society...

Australia's Creso Pharma Limited (ASX:CPH) says it has reached final stage of development for a new hemp-based lozenge product containing cannabidiolic acid (CBDA).The cannabinoids...